Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses"

Stroke. 2014 Dec;45(12):e304. doi: 10.1161/STROKEAHA.114.007363. Epub 2014 Oct 23.

Authors

Xiaoling Liao¹, Yilong Wang¹, Yongjun Wang¹

Affiliation

¹ Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Stroke, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China.

PMID: 25342031
DOI: 10.1161/STROKEAHA.114.007363

No abstract available

Publication types

Letter
Comment

MeSH terms

Brain Ischemia / drug therapy*
Female
Fibrinolytic Agents / therapeutic use*
Humans
Male
Stroke / drug therapy*
Thrombolytic Therapy / methods*
Tissue Plasminogen Activator / therapeutic use*

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator